GroGenesis to focus on biostimulant market

GroGenesis Inc. announced Thursday it will be focusing on distribution deals in the nascent biostimulant market, a $2.5 billion market segment of the agricultural industry that is expected to have a 12.5 percent compound average growth rate by 2019.

“We feel the biostimulant market has come a long way in a very short timeframe, and we look forward to working closely with some of the new and innovative technologies just coming to the forefront of the agricultural industry as a whole,” GroGenesis President and CEO Joe Fewer said.

With its flagship products in this area, AgraBurst and AgraBlast, the company will target South American countries as they are a major share holder of the global market. A Ceresana Research study states that crop protection products will likely surpass the $52 million market value threshold by 2019.

“Crop production and remediation products integrated with novel health enhancement programs are looking to be the future of agriculture in an increasingly stressed global environment," Fewer said. "The work we and others like us are doing today should have an immense impact on feeding future generations and we are fully aware that this represents a shifting economic and societal reality that we believe could present great future benefits for our company and shareholders alike.”

AgraBurst uses plant extracts to enhance the fertilizer's effect on growth. AgraBlast provides a non-toxic protection system as opposed to common fungicides, the company states.